KCM
OGN icon

Kennedy Capital Management’s Organon & Co OGN Stock Holding History

Kennedy Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-75,014
Closed -$1.3M – 706
2023
Q3 		$1.3M Sell
75,014
-604
-0.8% -$12.6K 0.03% 538
2023
Q2 		$1.57M Sell
75,618
-213
-0.3% -$4.63K 0.04% 502
2023
Q1 		$1.78M Buy
+75,831
New +$2.04M 0.05% 423

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Kennedy Capital Management's OGN Position: Q4 2023 in Review

Kennedy Capital Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 75,014 shares — an estimated $1.3M sold.

Kennedy Capital Management first reported a position in OGN in Q1 2023 and held it in 3 quarters. The position peaked at $1.78M in Q1 2023. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Kennedy Capital Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Kennedy Capital Management sold 75,014 Organon & Co shares in Q4 2023, an estimated $1.3M.
  • Kennedy Capital Management first reported a position in Organon & Co in Q1 2023 and held it in 3 quarters.
  • Kennedy Capital Management's Organon & Co position peaked at $1.78M in Q1 2023.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Kennedy Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.